Martin A. Lee is the co-founder and director of Project CBD and the author of several books, including Smoke Signals: A Social History of Marijuana–Medical, Recreational and Scientific, which received the American Botanical Council’s James A. Duke Award for Excellence in Botanical Literature. Named by High Times as one of the 100 most influential people in cannabis, he is the 2016 winner of the Emerald Cup’s Lifetime Achievement Award. Lee is also co-founder of the media watch group FAIR (Fairness & Accuracy In Reporting) and the author of Acid Dreams: The Complete Social History of LSD–The CIA, the Sixties and Beyond.
Martin A. Lee
When solar energy pioneer John Schaeffer sold the first photovoltaic panel to a U.S. retail customer in Mendocino County in 1978, he didn’t realize that he had struck a decisive blow against the war on drugs.
Scientific studies have established that synthetic, single-molecule CBD has a narrow therapeutic window and requires high doses for efficacy as compared to whole-plant, cannabis-derived CBD.
CBD and THC are the power couple of cannabis therapeutics, interacting to amplify one another’s curative properties. CBD enhances THC’s painkilling and anticancer properties, while lessening THC’s psychoactivity.
It’s widely known that olive oil has many health benefits, but only recently have scientists learned that important therapeutic attributes of olive oil are mediated by the endocannabinoid system.
There is growing interest among medical scientists in the gene-regulating properties of cannabidiol (CBD), the non-psychoactive plant cannabinoid. CBD reduces brain cancer and breast cancer cell proliferation and metastasis by inhibiting the expression of the ID-1 gene.